About LifeSprout
LifeSprout is a Healthcare company based in Baltimore (United States) founded in 2015 by Justin Sacks, Sashank Reddy, Russell Martin, Mohamed Benjelloun, and Hai-Quan Mao. It operates as a synthetic soft tissue substitutes for cosmetics and reconstructive surgery. LifeSprout has raised $44.7 million across 5 funding rounds from investors including Maryland.gov, Medytox and TEDCO. The company has 12 employees. Its chief executive is Sashank Reddy. LifeSprout offers products and services including Tissue Restoration Platform and Regenerative Medicine Suite. Its focus areas include Life Sciences, Regenerative Medicine, Biomaterials and Scaffolds. Its legal entity is LIFESPROUT, INC. Its competitors include Augmenix, AmacaThera, Regentis Biomaterials, Carbylan and Biosyntech and 4 more; 8 of its 9 listed competitors have raised funding.
Company details
LifeSprout was founded in 2015 in Baltimore, United States, within the biotechnology sector focused on tissue engineering. An injectable hydrogel product called Scaffold, composed of biodegradable nanofibers, is offered for applications in cancer reconstruction, trauma repair, and cosmetics. The material occupies space to support tissue growth, permits cell permeability, and dissolves in body fluids. It enables breast reconstruction for mastectomy patients without harvesting tissue from other areas.
- Headquarters Baltimore, United States
- Employees 12
- Founders Justin Sacks, Sashank Reddy, Russell Martin, Mohamed Benjelloun, Hai-Quan Mao
- SectorsHealthcare
- Website lifesproutbio.com
- Social LinkedIn
- Legal Name Lifesprout, Inc.
- Total Equity Funding$44.7M (USD)
in 5 rounds
- Latest Funding Round$28.5M (USD), Series A
Apr 2020
- InvestorsMaryland.gov
& 9 more
- Employee Count12
Products & Services of LifeSprout
LifeSprout offers a comprehensive portfolio of products and services, including Tissue Restoration Platform and Regenerative Medicine Suite.
Products that mimic body tissues for soft tissue restoration purposes
Suite of products for enhancing form and function in patients
Funding Insights of LifeSprout
LifeSprout has successfully raised a total of $44.7M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $28.5 million completed in April 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $44.7M
- Total Rounds 5
- Last Round Series A — $28.5M
- First Round $2.7M
(Feb 2018)
- Investors Count 10
All 5 funding rounds of LifeSprout with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2020 | $28.5M | Series A | – | Redmile Group | |
| May 2019 | $6.5M | Series A | – | Kairos Ventures, TEDCO | – |
| Jun 2018 | $6.5M | Series A | – | Kairos Ventures, Triskelion Capital | |
| Mar 2018 | $500,000 | Seed | – | TEDCO | – |
| Feb 2018 | $2.7M | Seed | – | – | – |
10 investors in total: 10 institutional.
Investors in LifeSprout
LifeSprout has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include Maryland.gov, Medytox and TEDCO.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage venture capital investments are provided by Emerald. | – | emeraldmanagers.com | New York, United States | |
Venture capital firm focused on life sciences, physical sciences, and technology companies | – | kairosventures.com | Beverly Hills, United States | |
Venture capital fund and startup accelerator programs focused on seed and early stage companies | 1998 | tedcomd.com | Columbia, United States | |
- | – | triskelion.capital | - | |
- | – | ginkgo.net.cn | - | |
Operates as an employee-owned hedge fund focused on long/short equity strategies. | 2007 | redmilegroup.com | San Francisco, United States | |
Provides grants and investments to support health, education, and community development in Baltimore. | 1953 | abell.org | Baltimore, United States | |
Botulinum toxins, synthetic drugs, supplements, and medical devices are developed. | 2000 | medytox.com | Seoul, South Korea | |
Access to government programs and development services is facilitated. | – | maryland.gov | United States | |
- | – | nexusmgmt.com | - |
Investor details for LifeSprout
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of LifeSprout
9 people are tracked at LifeSprout (7 in leadership, 2 in team); the tracked headcount is 12.
| Name | Role | Group |
|---|---|---|
Justin Sacks | Co-Founder | Leadership |
Sashank Reddy | Co-Founder & CEO | Leadership |
Russell Martin | Co-Founder | Leadership |
Mohamed Benjelloun | Co-Founder | Leadership |
Hai-Quan Mao | Co-Founder | Leadership |
Gordon Holt | Vice President of Translational R&D | Leadership |
Aron Rosenberg | Director Of Technical Operations | Leadership |
Kevin Colbert | Operations & BD Consultant | Team |
Paul H. Williamson | Senior Process Development Engineer | Team |
Complete people profiles for LifeSprout
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of LifeSprout
3 dated milestones of LifeSprout across 5 years, from founding to its latest funding, stage changes and deals.
- Founded LifeSprout is founded.
- Funding First funding round of $2.7M.
- Funding Latest funding round, Series A, of $28.5M.
Competitors of LifeSprout
LifeSprout has 9 listed competitors in our database, 8 of them funded. They include Augmenix, AmacaThera, Regentis Biomaterials, Carbylan and Biosyntech, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| augmenix.com | 2008 | Waltham, United States | $46.6M | 153 | Hydrogel spacers are provided for prostate cancer radiation therapy. | |
| amacathera.ca | 2015 | Toronto, Canada | $14.22M | – | Injectable hydrogel platform developed for therapeutic medical applications. | |
| regentis.co.il | 2004 | Or Akiva, Israel | $25M | – | Regentis Biomaterials is focused on tissue repair hydrogel technology. | |
| carbylan.com | 2004 | Palo Alto, United States | $42.9M | 7 | Hyaluronic acid polymers are developed into therapeutics for pain management. | |
| biosyntech.com | 1994 | Laval, Canada | $1.4M | – | Biotherapeutic thermogels are developed for tissue repair applications. | |
| lonestarheartinc.com | 2010 | Laguna Hills, United States | $45.18M | 2 | Develops cardiac therapies for patients with chronic heart failure. | |
| ecmtherapeutics.com | 2018 | Warrendale, United States | $26.1M | – | Diagnostic and therapeutic products from extracellular matrix are developed. | |
| glycosan.com | 2006 | Alameda, United States | $950,000 | – | Biocompatible hydrogels mimicking extracellular matrix are developed for tissue engineering. | |
| cartilagen.com | 2015 | Iowa, United States | – | – | Smart biomaterials are developed for knee cartilage repair. |
Detailed competitors of LifeSprout
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Organ-on-Chip & Regenerative Solutions
10 companies that operate in the same segment as LifeSprout (Organ-on-Chip & Regenerative Solutions), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Human tissue-based products are developed for vascular disease applications. | 2004 | Morrisville, United States | USD 424.76 M | USD 2.04 M | 220 | |
Fish-skin acellular dermal matrix technology is provided for wound treatments. | 2007 | Isafjordur, Iceland | USD 93.11 M | – | 150 | |
Products for regenerative and respiratory medicine are developed and distributed. | 1992 | Cambridge, Cambridgeshire, United Kingdom | – | USD 71.61 M | 260 | |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | 1985 | Marietta, Georgia, United States | – | USD 418.63 M | 837 | |
Personalized skin tissue therapy is developed by CUTISS for surgeries. | 2017 | Zurich, Switzerland | USD 94.37 M | – | – | |
Synthetic adhesives for bone and dental repair are developed. | 2014 | Lowell, Massachusetts, United States | USD 24.42 M | – | – | |
Injectable synthetic bone substitutes are developed for fracture treatment. | 2000 | Lund, Sweden | USD 101.08 M | USD 127.04 M | 139 | |
Provider of in vivo stem cell modification technologies and vector-based drug delivery tool | 2019 | Boston, Massachusetts, United States | USD 205 M | – | 52 | |
Regenerative therapies for wound care are developed and commercialized. | 1985 | Canton, Ohio, United States | USD 30 M | USD 564.17 M | 869 | |
Reconstructive and regenerative solutions for bone conditions are developed. | 1980 | Lewisville, Texas, United States | – | USD 822.31 M | 1,620 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lifesprout
Complete news archive for LifeSprout
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LifeSprout
LifeSprout was founded in 2015 and raised its 1st funding round 3 years after it was founded.
LifeSprout is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.
Sashank Reddy is the current CEO of LifeSprout. They have also founded this company.
LifeSprout is a funded company, having raised a total of $44.7M across 5 funding rounds to date. The company's 1st funding round was a Seed of $2.7M, raised on Feb 2018.
LifeSprout has 12 employees.
LifeSprout was founded in 2015 in Baltimore, United States, within the biotechnology sector focused on tissue engineering. An injectable hydrogel product called Scaffold, composed of biodegradable nanofibers, is offered for applications in cancer reconstruction, trauma repair, and cosmetics. The material occupies space to support tissue growth, permits cell permeability, and dissolves in body fluids. It enables breast reconstruction for mastectomy patients without harvesting tissue from other areas.
LifeSprout's top competitors include AmacaThera, Augmenix and Regentis Biomaterials.
LifeSprout offers Tissue Restoration Platform and Regenerative Medicine Suite.
LifeSprout has 10 investors. Key investors include Maryland.gov, Medytox, TEDCO, Redmile Group, and nexusmgmt.com.
LifeSprout operates through Lifesprout, Inc..